Mediwound Ltd reported break-even for the forth quarter of 2023 compare to net loss per share of $-0.34 recorded in the same quarter a year ago an improvement compare to $0.00 realized in previous quarter.
forth quarter of 2023
Earnings Per Share
Revenues
$ 0
$
0 Mill
$+0.34
$-22M
Mediwound Ltd 's Revenue
fell by
0 % in forth quarter of 2023 (Dec 31 2023) year on year,
to $0 million and
declined by
sequentially.
Mediwound Ltd in the forth quarter of 2023 recorded net loss of $0.000 million, an improvement compare to net loss of $-9.196 million in IV. Quarter a year ago.
Sequentially
net loss narrowed from net loss of $0.000 million realized in previous quarter.
Mediwound Ltd Inventories MDWD's Cash flow
In the forth quarter of 2023 company's net cash flow was $34 million, capital expenditures fell by -0.923600.33%, to $-6 millions compare to same quarter a year ago
Mediwound Ltd, a leading innovator in burn and wound care treatments, has experienced a decline of 10.77% in its shares during March 2024, which brings the share price to 39.82% for the first quarter of 2024. Despite this decline, the shares are trending higher and are just 8.8% short of reaching its 52-week high. The company's financial results for 2023 indicate that it generated $19 million in revenue, and it has projected revenue of $24 million for 2024. Furthermore, Mediwound successfully launched its product called NexoBrid in the United States, Japan, and India. This achievement is a significant milestone for the company, as NexoBrid aims to offer a non-surgical solution for pediatric patients in t...